Adenocarcinoma of the Esophagus: Risk factors and prevention

ONCOLOGY

Volumn 14, Issue 4, 2000, Pages 507-514

  Heath, Elisabeth I ^a   Limburg, Paul J ^b   Hawk, Ernest T ^b   Forastiere, Arlene A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIASTHMATIC AGENT;

ADENOCARCINOMA; BARRETT ESOPHAGUS; DIET; DRINKING BEHAVIOR; ESOPHAGUS ACHALASIA; ESOPHAGUS TUMOR; HUMAN; PEPTIC ULCER; REVIEW; RISK FACTOR; SMOKING; SQUAMOUS CELL CARCINOMA; SYSTEMIC SCLEROSIS;

ADENOCARCINOMA; ALCOHOL DRINKING; ANTI-ASTHMATIC AGENTS; BARRETT ESOPHAGUS; CARCINOMA, SQUAMOUS CELL; DIET; ESOPHAGEAL ACHALASIA; ESOPHAGEAL NEOPLASMS; HUMANS; PEPTIC ULCER; RISK FACTORS; SCLERODERMA, SYSTEMIC; SMOKING;

EID: 0034167639     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Greenlee RT, Murray T, Bolden S, et al: cancer statistics, 2000. CA Cancer J Clin 50:7-33, 2000.
2. Blot WJ, Devessa SS, Kneller RW: Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 265:1287-1289, 1991.
3. Devesa SS, Blot WJ, Fraumeni JF: Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83:2049-2053, 1998.
4. Chalasani N, Wo JM, Waring JP: Racial differences in the histology, location, and risk factors of esophageal cancer. J Clin Gastroenterol 26-M-13, 1998.
5. Spechler SJ, Goyal RK: Barrett's esophagus. N Engl J Med 315:362-311, 1986.
6. Champion G, Richter JE, Vaezi MF, et al: Duodenogastroesophageal reflux: Relationship to pH and importance in Barrett's esophagus. Gastroenterology 107:747-754, 1994.
7. Colleen MJ, Lewis JH, Benjamin SB: Gastric acid hypersecretion in refractory gastroesophageal reflux disease. Gastroenterology 98:654-661, 1990.
8. Provenzale D, Kemp JA, Arora S, et al: A guide for surveillance of patients with Barrett's esophagus. Am J Gastroenterol 89:670-680, 1994.
9. Cameron AJ, Ott BJ, Payne WS: The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N Engl J Med 313:857-859, 1985.
10. Drewitz DJ, Sampliner RE, Garewal HS: The incidence of adenocarcinoma in Barrett's esophagus: A prospective study of 170 patients followed 4.8 years. Am J Gastroenterol 92:212-215, 1997.
11. Winters C, Spurling TJ, Chobanian SJ, et al: Barrett's esophagus: A prevalent occult complication of gastroesophageal reflux disease. Gastroenterology 92:118-124, 1987.
12. Cameron AJ, Zinsmeister AR, Ballard DJ, et al: Prevalence of columnar-lined Barrett's esophagus: Comparison of population based on clinical and autopsy findings. Gastroenterology 99:918-22, 1990.
13. Lagergren J, Bergstrom R, Lindgren A, et al: Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 340:825-831, 1999.
14. Sandier RS, Nyren O, Ekbom A, et al: The risk of esophageal cancer in patients with achalasia. JAMA 274:1359-1362, 1995.
15. Loviscek LF, Cenoz MC, Badaloni AE, et al: Early cancer in achalasia. Dis Esophagus 11:239-247, 1998.
16. Halpert RD, Laufer I, Thompson JJ, et al: Adenocarcinoma of the esophagus in patients with scleroderma. Am J Roentgenol 140:927-930, 1983.